Cargando…
Should S-1 be better than capecitabine for patients with advanced gastric cancer in Asia? A systematic review and meta-analysis
BACKGROUND: S-1 or capecitabine (Cap) containing treatment is an increasingly used strategy in patients with advanced gastric cancer in Asia. It is unclear whether there is sufficient evidence to support which regimen is better. METHODS: A systematic review of retrospective studies and randomized co...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312060/ https://www.ncbi.nlm.nih.gov/pubmed/30643425 http://dx.doi.org/10.2147/OTT.S187815 |